scispace - formally typeset
S

Søren Gregersen

Researcher at Aarhus University Hospital

Publications -  102
Citations -  3917

Søren Gregersen is an academic researcher from Aarhus University Hospital. The author has contributed to research in topics: Insulin & Type 2 diabetes. The author has an hindex of 28, co-authored 93 publications receiving 3274 citations. Previous affiliations of Søren Gregersen include Steno Diabetes Center & Aarhus University.

Papers
More filters
Journal ArticleDOI

Antihyperglycemic effects of stevioside in type 2 diabetic subjects

Søren Gregersen, +3 more
- 01 Jan 2004 - 
TL;DR: It is hypothesized that supplementation with stevioside to a test meal causes a reduction in postprandial blood glucose levels in type 2 diabetic patients, indicating beneficial effects on the glucose metabolism.
Journal ArticleDOI

Impact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation.

Knud Erik Bach Knudsen, +12 more
- 13 Oct 2018 - 
TL;DR: The effect of butyrate seems generally to be more consistent and positive oninflammatory markers related to the gut than on inflammatory markers in the peripheral tissue, and this discrepancy may be explained by differences inbutyrate concentrations in the gut compared with the much lower concentration at more remote sites.
Journal ArticleDOI

Stevioside acts directly on pancreatic β cells to secrete insulin: Actions independent of cyclic adenosine monophosphate and adenosine triphosphate—sensitivie K+-channel activity

P. B. Jeppesen, +7 more
- 01 Feb 2000 - 
TL;DR: Stevioside and steviol stimulate insulin secretion via a direct action on beta cells and may have a potential role as antihyperglycemic agents in the treatment of type 2 diabetes mellitus.
Journal ArticleDOI

Stevioside induces antihyperglycaemic, insulinotropic and glucagonostatic effects in vivo: studies in the diabetic Goto-Kakizaki (GK) rats.

Per Bendix Jeppesen, +3 more
- 01 Jan 2002 - 
TL;DR: Stevioside exerts antihyperglycaemic, insulinotropic, and glucagonostatic actions in the type 2 diabetic GK rat, and may have the potential of becoming a new antidiabetic drug for use in type 2 diabetes.
Journal ArticleDOI

Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat.

Per Bendix Jeppesen, +9 more
- 01 Mar 2003 - 
TL;DR: Stevioside enjoys a dual positive effect by acting as an antihyperglycemic and a blood pressure-lowering substance; effects that may have therapeutic potential in the treatment of type 2 diabetes and the metabolic syndrome.